ArticlebioRxiv : the preprint server for biology2024
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer.
Nina Marie G Garcia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.